tiprankstipranks
Trending News
More News >
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
FRANKFURT:3759
Hong Kong Market

Pharmaron Beijing Co., Ltd. Class H (3759) Income Statement

Compare
10 Followers

Pharmaron Beijing Co., Ltd. Class H Income Statement

Last quarter (Q3 2025), Pharmaron Beijing Co., Ltd. Class H's total revenue was ¥3.92B, an increase of 22.04% from the same quarter last year. In Q3, Pharmaron Beijing Co., Ltd. Class H's net income was ¥480.24M. See Pharmaron Beijing Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 12.28B¥ 11.54B¥ 10.27B¥ 7.44B¥ 5.13B
Gross Profit
¥ 4.20B¥ 4.12B¥ 3.77B¥ 2.68B¥ 1.92B
Operating Expenses
¥ 2.10B¥ 2.28B¥ 2.02B¥ 1.15B¥ 838.94M
Depreciation and Amortization
¥ 1.05B¥ 927.17M¥ 696.18M¥ 497.92M¥ 375.16M
EBITDA
¥ 3.38B¥ 2.95B¥ 2.53B¥ 2.49B¥ 1.72B
Operating Income
¥ 2.10B¥ 1.85B¥ 1.69B¥ 1.91B¥ 1.32B
Other Income/Expenses
¥ -13.20M¥ -10.01M¥ -23.50M¥ -3.34M¥ -4.47M
Pretax Income
¥ 2.09B¥ 1.84B¥ 1.67B¥ 1.91B¥ 1.32B
Net Income
¥ 1.79B¥ 1.60B¥ 1.37B¥ 1.66B¥ 1.17B
Per Share Metrics
Basic EPS
¥ 1.01¥ 1.00¥ 0.90¥ 1.12¥ 0.74
Diluted EPS
¥ 1.01¥ 1.00¥ 0.90¥ 1.10¥ 0.74
Weighted Average Shares Outstanding
1.79B 1.77B 1.77B 1.78B 1.78B
Weighted Average Shares Outstanding (Diluted)
1.79B 1.78B 1.78B 1.81B 1.78B
Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History